Arcalyst 220 MG vials
Ended Awarded
- Contract number
- SPE2DR26FKKC6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,599
Award facts
- Contract value 100% obligated
- $16,599.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,599.01 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Arcalyst 220 mg vials. The delivery order, issued on November 18, 2025, with an ultimate completion date of December 10, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This award operates under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was established on November 13, 2025, with a $499,999,999 ceiling value through December 31, 2036.
The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs for Department of Defense healthcare facilities worldwide. As one of multiple regional prime vendor contractors under this initiative, DMS Pharmaceutical Group has demonstrated substantial performance capability through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, supplying a comprehensive range of pharmaceuticals including specialty medications, biologics, vaccines, and medical consumables to military healthcare operations. The current delivery order for Arcalyst, a specialty pharmaceutical product, reflects the contractor's established role as a critical pharmaceutical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FKKC6?
SPE2DR26FKKC6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FKKC6 worth?
The government has obligated $16,599 on SPE2DR26FKKC6.
Is contract SPE2DR26FKKC6 an order under another contract?
Yes. SPE2DR26FKKC6 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKC6 competed?
The extent of competition for SPE2DR26FKKC6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award